APhA DRUG<i>Info</i>LINE®
2019 © American Pharmacists Association
L. Michael Posey, BPharm


Newly updated, completely revamped and substantially improved, the APhA DrugInfoLINE® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep front line pharmacists current on the latest trends in the biomedical literature. This unique STAT!Ref resource contains current, searchable information not available in any other similarly compiled format.

Available in the convenient, cross-searchable STAT!Ref platform, APhA DrugInfoLINE includes regular coverage of these areas:

  • Neurology
  • Psychiatry
  • Cardiology: Focus on Lipids Care; Focus on Anticoagulation Care
  • Respiratory: Focus on Asthma Care
  • Gastroenterology
  • Nephrology
  • Endocrinology: Focus on Diabetes Care
  • Rheumatology
  • Infectious Diseases: Focus on HIV Care; Focus on Immunizations
  • Oncology


  • Alternative Medicines Corner
  • OTC Medicines Corner

Personalized Care:

  • Drug Interactions Corner
  • Pharmacogenomics Corner

Medication Monitor:

  • New Drug Approvals
  • Supplemental Approvals
  • Alerts and Recalls
  • Product Withdrawals

About the American Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

This title updates: Weekly

Table of Contents

Similar Resources